Company: AGIO
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001439222-25-000116
Chunk: 129

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-10-30
Form: 10-Q
Item: Part I, Item 1
Chunk 129
---
 $— $2,674 U.S. Treasuries133,848 172 (31)133,989 Government securities137,907 83 (30)137,960 Corporate debt securities584,904 683 (60)585,527 Total current859,331 940 (121)860,150 Non-current:U.S. Treasuries154,462 743 (7)155,198 Government securities38,472 31 (8)38,495 Corporate debt securities110,175 488 (15)110,648 Total non-current303,109 1,262 (30)304,341 Total marketable securities$1,162,440 $2,202 $(151)$1,164,491 

10

Marketable securities at December 31, 2024 consisted of the following:(In thousands)AmortizedCostUnrealizedGainsUnrealizedLossesFairValueCurrent:Certificates of deposit$10,374 $11 $— $10,385 U.S. Treasuries173,465 153 (27)173,591 Government securities167,970 103 (75)167,998 Corporate debt securities465,427 321 (259)465,489 Total current817,236 588 (361)817,463 Non-current:U.S. Treasuries107,725 106 (303)107,528 Government securities112,175 3 (469)111,709 Corporate debt securities420,166 181 (1,263)419,084 Total non-current640,066 290 (2,035)638,321 Total marketable securities$1,457,302 $878 $(2,396)$1,455,784 As of September 30, 2025 and December 31, 2024, we held both current and non-current investments. Investments classified as current have maturities of less than one year. Investments classified as non-current are those that: (i) have a maturity of greater than one year, and (ii) we do not intend to liquidate within the next twelve months, although these funds are available for use and, therefore, are classified as available-for-sale.As of September 30, 2025 and December 31, 2024, we held 58